CNTB (Connect Biopharma Holdings) EV-to-EBITDA : -1.93 (As of Jul. 05, 2025)

Connect Biopharma Holdings EV-to-EBITDA Chart

Connect Biopharma Holdings Quarterly Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Mar24	Jun24	Dec24	Mar25
EV-to-EBITDA	Get a 7-Day Free Trial							0.77	-7.71	-3.16	0.79	-5.60

Competitive Comparison of Connect Biopharma Holdings's EV-to-EBITDA

For the Biotechnology subindustry, Connect Biopharma Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Connect Biopharma Holdings's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Connect Biopharma Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Connect Biopharma Holdings's EV-to-EBITDA falls into.

Connect Biopharma Holdings EV-to-EBITDA Calculation

Connect Biopharma Holdings's EV-to-EBITDA for today is calculated as:

Connect Biopharma Holdings's current Enterprise Value is $-18.09 Mil.
Connect Biopharma Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Connect Biopharma Holdings  (NAS:CNTB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Connect Biopharma Holdings's PE Ratio (TTM) for today is calculated as:

Connect Biopharma Holdings's share price for today is $1.1693.
Connect Biopharma Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Connect Biopharma Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings Business Description